Variable | n = 41 | Range |
---|---|---|
Age (median, years) | 55.0 | 33–73 |
Follow-up (median, months) | 46.0 | |
Length of stay (days) | ||
ICU | 4.5 | 1–32 |
Hospital | 29.3 | 7–82 |
Operating time (mean, h) | 8.2 | 4–14 |
Variable | n = 41 | n (%) |
---|---|---|
Presentation | ||
Primary | 11 | 27 |
Recurrent | 30 | 73 |
Tumour origin | ||
Ovarian | 33 | 80 |
Fallopian tube | 4 | 10 |
Peritoneal | 4 | 10 |
Histology | ||
High grade serous | 32 | 78 |
Endometrioid | 0 | 0 |
Mucinous | 3 | 7 |
Clear cell | 1 | 2 |
Low grade serous | 5 | 12 |
Peritoneal Cancer Index (PCI) | ||
≤ 15 | 13 | 32 |
> 15 | 28 | 68 |
Completeness of cytoreduction (CC score) | ||
0 | 24 | 59 |
1 | 16 | 39 |
2 | 1 | 2 |
3 | 0 | 0 |
HIPEC | ||
Yes | 29 | 71 |
No | 12 | 29 |
Complications (Clavien-Dindo) | ||
None | 9 | 22 |
Grade 1/2 | 17 | 41 |
Grade 3/4 | 14 | 34 |
Death | 1 | 2 |